News

The supplemental premarket approval application is supported by Phase III data, which showed significant improvements in neck ...
Treatment with 300 mg IV eptinezumab in adults with chronic migraine resulted in rapid and sustained reduction in the number of headache days that was largely sustained up to 84 weeks, according to a ...
Irvine: AbbVie's Allergan Aesthetics has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental premarket approval (sPMA) application for SKINVIVE ...
The private non-profit foundation created by the state and local governments to distribute opioid settlement dollars in West Virginia received an update Monday on its funding and grant programs. The ...
Incyte Corporation (NASDAQ:INCY) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer ...
AbbVie Inc. and other drug makers lost a bid to block a Tennessee law regulating contracts between pharmaceutical companies ...
Berks Plastic Surgery has released a patient-friendly blog, “Motiva Implant Profiles, Explained,” in which board-certified ...
The private non-profit foundation created by the state and local governments to distribute opioid settlement dollars in West Virginia received an update Monday on its funding and grant programs. The ...
The private nonprofit foundation created by the state and local governments to distribute opioid settlement dollars in West Virginia received an update Monday on its funding and grant programs. The ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Incyte’s Hervé Hoppenot is hanging up his hat after spending more than a decade building the company into the ...
After over a decade spent building Incyte up into a competitive commercial drugmaker, the company’s longtime CEO Hervé ...